TIRAT CARMEL, Israel, May 15, 2018 /PRNewswire/ --
Medic Vision Imaging Solutions, Ltd., the leading innovatorof vendor-independent solutions for CT and MRI scanners, today announced that the U.S. Food and Drug Administration (FDA) has cleared its latest product, iQMR™ (intelligent Quick MR).
Medic Vision's new iterative image reconstruction technology
"Medic Vision has established its dominance as the leading trusted provider of 3rd party CT dose management and reduction solutions. Currently, Medic Vision's flagship CT products: SafeCT and SafeCT-29, are in routine clinical use at more than 500 sites across the US and have saved our clients over $50M," said Medic Vision CEO, Eyal Aharon. With the addition of iQMR image enhancement capabilities, Medic Vision will now be able to offer the diagnostic imaging industry a ground-breaking solution allowing any MRI operator to save cost, improve its productivity and boost patients experience and profitability.
Medic Vision will showcase iQMR at the upcoming ASNR 56th Annual Meeting. At the meeting, Prof. Lawrence N. Tanenbaum, M.D., FACR, VP and Director of CT, MR & Advanced Imaging at RadNet, will present the results of a clinical study demonstrating the ability to reduce routine brain exam scan time by 30% without adversely affecting image quality using iQMR.
About Medic Vision
Founded in 2006, Medic Vision is the leading innovator of vendor-independent, cost-effective, image enhancement and dose management solutions for CT and MRI scanners. Medic Vision's line of innovative 3D iterative image enhancement products is based on sophisticated proprietary algorithms, and is in routine clinical use at major hospitals and imaging centers nationwide. For more information, visit http://www.medicvision.com, follow us on Twitter and find us on LinkedIn.
Media Contact: Dana Carmiel Shterman, Marketing Manager, email@example.com
SOURCE Medic Vision Imaging Solutions, Ltd
Subscribe to our Free Newsletters!